EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

How population-level drug supply data are integrated into health outcomes research: a scoping review

Samuel Tobias iD, Joshua Bird iD, Michael R Law iD, Jane A Buxton, Lianping Ti iD

Epidemiologic Reviews · 29.01.2026 · 48 (1)

DOI: 10.1093/epirev/mxag010 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Epidemiologic Reviews, online erschienen am 11.05.2026. Verfasst von Samuel Tobias und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Substance-Related Disorders, Outcome Assessment, Health Care, Illicit Drugs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: US National Institute on Drug Abuse, Canada Research Chair, Canadian Institutes of Health Research Canada Graduate Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite growing recognition that changes in the unregulated drug supply are central drivers of drug-related morbidity and mortality, there is little consensus on how population-level drug supply data are, or should be, incorporated into health outcomes research. Here, we describe the role unregulated drug supply data play in health outcomes research in the substance use field. We searched the MEDLINE, Embase, Scopus, and Europe PubMed Central databases and relevant published conference abstracts on May 28, 2025. Studies must have incorporated population-level or ecological measures of the unregulated drug supply (i.e., nonpharmaceutical) as an independent variable and reported either individual-level or population-level health outcomes, including but not limited to drug poisonings (i.e., overdose), deaths (drug-related or all-cause), hospitalizations, and emergency department visits. Of the 31 included studies, 26 were conducted in the United States and 5 in Canada. Drug supply data were used in multiple analytic roles, including as primary variables and as covariates (or predictors) of health outcomes. These data were derived from 4 distinct sources: law enforcement seizures (n = 25), drug-checking services (n = 2), hospital or clinic urinalysis results (n = 3), or postmortem toxicology results (n = 3). Most studies assessed the impact of drug supply metrics on drug toxicity (overdose) counts or rates within a given region (n = 27). We found that population-level drug supply data demonstrate predictive capacity for health outcomes and may represent an underutilized confounding factor in policy evaluation. However, their incorporation into health research remains inconsistent and conceptually fragmented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersOutcome Assessment, Health CareIllicit DrugsHumansUnited States

Stichwörter der Autor:innen

causalityepidemiologyfentanylharm reductionlaw enforcementpopulation healthscoping review

Substanzen

Illicit Drugs

Autor:innen und Institutionen

  • School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
  • Department of Community Health Science, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Centre for Health Policy, O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Samuel Tobias, Joshua Bird, Michael R Law, Lianping Ti

Förderung

  • US National Institute on Drug Abuse
  • Canada Research Chair
  • Canadian Institutes of Health Research Canada Graduate Scholarship

Zitieren

APA

Tobias, S., Bird, J., Law, M. R., Buxton, J. A., & Ti, L. (2026). How population-level drug supply data are integrated into health outcomes research: a scoping review. Epidemiologic Reviews, 48(1). https://doi.org/10.1093/epirev/mxag010

Vancouver

Tobias S, Bird J, Law MR, Buxton JA, Ti L. How population-level drug supply data are integrated into health outcomes research: a scoping review. Epidemiologic Reviews. 2026;48(1). doi:10.1093/epirev/mxag010

BibTeX
@article{Tobias2026,
  author = {Tobias, Samuel and Bird, Joshua and Law, Michael R and Buxton, Jane A and Ti, Lianping},
  title = {How population-level drug supply data are integrated into health outcomes research: a scoping review},
  journal = {Epidemiologic Reviews},
  year = {2026},
  volume = {48},
  number = {1},
  doi = {10.1093/epirev/mxag010}
}
Kostenlos starten →